Furthermore, SLC41A1 was reported to be downregulated in human pancreatic ductal adenocarcinoma, and SLC41A1 overexpression inhibited cell proliferation and invasion, and suppressed orthotopic tumour growth in a mouse model 10. Here, SLC41A1 is linked to neoplasm.